Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell ‑based vaccines in murine colon carcinoma.
In conclusion, due to its immunomodulatory properties, the HES‑MTX nanoconjugate could become a potent anticancer agent used in both chemo‑ and chemoimmunotherapeutic treatment schemes.
PMID: 33432365 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Chemotherapy | Colon Cancer | Colorectal Cancer | Methotrexate | Nanotechnology | Study | Vaccines